Showing results (201-210 of 567) with videos related to
Sort By:
Pageof 57
Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine|October 22, 2008
Alteration of the amount and morphology of wear particles by the addition of loading profile transitions during artificial hip wear testingJ P Shorez, T S Harding, P J Atkinson, et al.Sexually Transmitted Infections|June 16, 2009
AIDS mortality in African migrants living in Portugal: evidence of large social inequalitiesL M Williamson, M Rosato, A Teyhan, et al.Psychopharmacology|November 20, 2004
Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in ratsA D Lê, S Harding, W Juzytsch, et al.The British Journal of Ophthalmology|January 1, 1993
Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studiesJ J Harding, M Egerton, R van Heyningen, et al.Yeast (Chichester, England)|August 23, 2000
Evaluation of the CaMAL2 promoter for regulated expression of genes in Candida albicansA C Backen, I D Broadbent, R W Fetherston, et al.Journal of Nephrology|January 12, 2000
Outcome of peritonitis treated with intraperitoneal (i.p.) weekly vancomycin and i.p. daily netilmicinD H Chadwick, S Agarwal, B J Vora, et al.Clinical and Experimental Immunology|July 1, 1996
Enhanced binding of lymphocytes from patients with multiple sclerosis to tumour necrosis factor-alpha (TNF-alpha)-treated endothelial monolayers: associations with clinical relapse and adhesion molecule expressionA J Vora, G D Perkin, T McCoy, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 22, 2001
(131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcinoid syndromeA A Pathirana, S Vinjamuri, C Byrne, et al.Diabetes Research and Clinical Practice|November 6, 1989
A supplementary infusion of glucose-dependent insulinotropic polypeptide (GIP) with a meal does not significantly improve the beta cell response or glucose tolerance in type 2 diabetes mellitusI R Jones, D R Owens, J Vora, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 1987
Renal response to intravenous somatostatin in insulin-dependent diabetic patients and normal subjectsJ Vora, D R Owens, S Luzio, et al.Pageof 57